View Older Stories View More Recent Stories

Sep 22, 2022 04:14PM NovaBay Pharma (NBY) CEO Issues Letter to Stockholders
Sep 22, 2022 04:05PM NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
Sep 13, 2022 06:50AM NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum
Sep 12, 2022 06:50AM NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance
Sep 9, 2022 08:01AM NovaBay Pharma (NBY) Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
Sep 9, 2022 08:00AM NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
Aug 11, 2022 04:05PM NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results
Aug 4, 2022 06:50AM NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11
Jul 28, 2022 06:50AM NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
Jul 21, 2022 06:50AM NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
Jul 15, 2022 06:50AM NovaBay Pharma (NBY) Reports Record Avenova Sales During Amazon’s Prime Day Event
Jul 15, 2022 06:50AM NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event
Jul 7, 2022 06:50AM NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America
May 12, 2022 04:05PM NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results
May 9, 2022 06:51AM NovaBay Pharma (NBY) Expands DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations
May 9, 2022 06:50AM NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations
May 5, 2022 06:50AM NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12
Apr 25, 2022 06:50AM NovaBay Pharma (NBY) CEO Issues Letter to Stockholders
Apr 25, 2022 06:50AM NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
Apr 11, 2022 06:50AM NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment
Apr 1, 2022 06:50AM NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line
Mar 29, 2022 04:05PM NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results
Mar 22, 2022 06:50AM NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29
Mar 9, 2022 06:53AM NovaBay Pharma's (NBY) DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line
Mar 9, 2022 06:50AM DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line
Feb 28, 2022 06:50AM NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest
Feb 23, 2022 06:51AM NovaBay Pharma (NBY) Partners with Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China
Feb 23, 2022 06:50AM NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China
Jan 28, 2022 06:51AM NovaBay Pharma (NBY) Announces Board Changes
Jan 28, 2022 06:50AM NovaBay Pharmaceuticals Announces Changes to Its Board of Directors
Jan 20, 2022 06:52AM NovaBay Pharma (NBY) Announced Donation of 2.5M KN95 Masks
Jan 20, 2022 06:52AM NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks
Jan 20, 2022 06:50AM NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Jan 10, 2022 06:54AM NovaBay Pharma (NBY) Launches Lubricating Eye Drops
Jan 10, 2022 06:50AM NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
Jan 4, 2022 06:50AM NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
Dec 21, 2021 06:50AM NovaBay Pharmaceuticals Holds Special Meeting of Stockholders
Dec 13, 2021 10:59AM DERMAdoctor’s Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance
Nov 18, 2021 06:50AM NovaBay Pharma (NBY) CEO's Letter to Stockholders
Nov 18, 2021 06:50AM NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
Nov 11, 2021 04:05PM NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results
Nov 8, 2021 06:50AM NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition
Nov 3, 2021 06:50AM NovaBay Pharmaceuticals Closes $15.0 Million Private Placement
Nov 1, 2021 08:35AM NovaBay Pharma (NBY) Prices 15,000 Share Preferred Private Placement at $1,000/sh
Nov 1, 2021 08:30AM NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement
Sep 29, 2021 06:50AM NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor
Sep 28, 2021 08:01AM NovaBay Pharma (NBY) to Acquire DERMAdoctor for $15M
Sep 28, 2021 08:00AM NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor
Sep 8, 2021 06:50AM NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference
Aug 12, 2021 04:05PM NovaBay Pharmaceuticals Reports Second Quarter 2021 Financial Results
View More Recent Stories View Older Stories